T cells

Life Sciences cybersecurity, knowing your first line of defense and continuously improving it

Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been attacked between seven and fifteen times,2 and 95% of attacks in the industry being IP theft related.2 With these sobering statistics — and the frequency of news reports about cyberattacks against private companies and critical infrastructure in both the U.S. and abroad — it stands to reason that cybersecurity is top of mind for business leaders and technology providers in the Life Sciences space today. The industry carries the weighty responsibilities of safeguarding patient safety, data privacy, and intellectual property (IP).

Read More